PHAT · Phathom Pharmaceuticals, Inc. · Documents
Market Cap
$676.33M
Shares
80.90M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-06-23 | — | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-21 | 2026-05-19 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| Investor Event Transcript | 2026-04-15 | 2026-06-30 | |
| DEF 14A | 2026-04-07 | 2026-05-19 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-08 | 2026-01-07 | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-30 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-27 | 2025-10-25 | |
| 8-K | 2025-10-06 | 2025-10-02 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-16 | — | |
| 8-K | 2025-06-09 | 2025-06-03 | |
| 8-K | 2025-06-06 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-23 | 2025-06-03 | |
| 8-K | 2025-04-16 | 2025-04-11 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 8-K | 2025-03-06 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2024-12-11 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-08-19 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-18 | — | |
| 10-K/A | 2024-06-14 | 2023-12-31 | |
| 10-Q/A | 2024-06-14 | 2024-03-31 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-12 | 2024-05-23 | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2023-12-15 | 2023-12-13 | |
| 8-K | 2023-12-14 | — | |
| 8-K | 2023-12-06 | — |
Showing 1–50 of 135 filings